Corrigendum to "Dihydroartemisin inhibits glioma invasiveness via a ROS to P53 to β-catenin signaling" [Pharmacol. Res. 119 (2017) 72-88].Zhongyou Que,Ping Wang,Yi Hu,Yixue Xue,Xiaobai Liu,Chengbin Qu,Jun Ma,Yunhui LiuPharmacological research（2021）引用 31|浏览12暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
